Navigation Links
More than 2,100 Stryker Hip Lawsuits Included in New Jersey Litigation after Settlement Announcement, Bernstein Liebhard LLP Reports
Date:11/28/2014

New York, New York (PRWEB) November 28, 2014

More than 2,100 Stryker hip lawsuits (http://www.consumerinjurylawyers.com/stryker-rejuvenate/stryker-hip-lawsuits/) have now been filed in a New Jersey litigation that involves a pair of recalled metal implants, Bernstein Liebhard LLP reports.

A Case List updated on November 18th in Bergen County Superior Court reflects the filing of 2,160 claims over the Rejuvenate and ABG II modular-neck hip stems, which were voluntarily recalled on July 6, 2012 by their manufacturer, Stryker Orthopaedics. Plaintiffs in these lawsuits allege pain, swelling, a loss of mobility and symptoms associated with metallosis (metal ion poisoning) caused by the implants, which they claim to have been inadequately warned about prior to their being taken off the market. (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)

“We are not surprised to see additional lawsuits continuing to be filed in New Jersey’s metal hip litigation, as we continue to hear from clients who need to have their Rejuvenate and/or ABG II modular-neck hip stems revised,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free and confidential case evaluations to potential plaintiffs in Stryker recall lawsuits.

Stryker Hip Litigation
Before the New Jersey Stryker litigation issued its most recent update, the court announced a settlement that could resolve thousands of claims filed in state and federal courts over the recalled Rejuvenate and ABG II implants. According to documents released on November 3rd, the global settlement program provides for base awards of $300,000 per failed implant, which could vary depending on complications suffered during revision surgery, and other damages that may include future surgeries caused by the complications. Claimants who are medically unable to undergo revision surgery but need to do so will also be provided damage awards through the agreement, which will likely be received by the summer of 2015, the documents stipulate. All Stryker lawsuits in this litigation were filed after the 2012 recall, and similarly allege fretting and corrosion of the Rejuvenate and ABG II devices’ metal components.

In addition to Stryker recall claims filed in New Jersey, thousands of others have also been centralized in a federal multidistrict litigation established in the U.S. District Court, District of Minnesota. A Case List updated on November 17th shows that 2,179 cases have now been filed in the proceeding. Counsel involved in this proceeding are also signatories to the Stryker hip settlement agreement. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, No. 244)

Rejuvenate and ABG II hip stem recipients may be eligible for compensation if they experienced complications related to the Stryker hip recall. To learn more, please visit Bernstein Liebhard LLP’s website. To arrange for a free case review, please call 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/stryker-hip-lawsuit/stryker-hip-recall/prweb12357037.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Metabolomics Market Worth $2,100 Million by 2019 - New Report by MarketsandMarkets
2. Metabolomics Market Worth $2,100 Million by 2019 - New Report By MarketsandMarkets
3. Stryker Hip Lawsuit News: Rejuvenate and ABG II Hip Lawsuit Filings Near 2,100 in New Jersey Litigation, Bernstein Liebhard LLP Reports
4. Centurion to Host Live Auction to Sell Over 2,100 Pieces of Medical Equipment
5. More than 2,100 GranuFlo Lawsuits Now Filed in Federal Dialysis Drug Litigation, Bernstein Liebhard LLP Reports
6. US Drug Watchdog Has Added Wright, Stryker, Biomet, and Zimmer To Their Initiative For All Metal Hip Implant Failures Victims & Offers Them The Names Of The Best Lawyers
7. US Drug Watchdog Now Offers DePuy, Stryker, Biomet, Zimmer, and Wright All Metal Hip Implant Failure Victims the Names of the Best Law Firms-Don't Get Left Holding the Bag
8. US Drug Watchdog Now Offers Recipients Of A DePuy, Wright, Stryker, Biomet or Zimmer Metal on Metal Hip Implant The Names of the Best Law Firms If Their Hip Has Failed
9. US Drug Watchdog Now Urges All Zimmer, Stryker, Biomet, Wright and DePuy Metal Hip Implant Recipients to Get Blood Tests
10. Stryker Hip Recall Lawsuits Being Evaluated by Bernstein Liebhard LLP, Following Recall of Stryker Rejuvenate and ABG II Modular Neck Stems
11. US Drug Watchdog Now Urges All Zimmer Stryker, Biomet, Wright and DePuy All Metal Hip Implant Recipients to Get A Blood Test For A Failure-Don't Get Left Holding the Bag
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2017)... ... August 18, 2017 , ... ... a transparent, verifiable database to help the cannabis industry move towards greater legitimacy. ... to deliver a faster technology with lower fees. Paragon will build a fully ...
(Date:8/19/2017)... ... August 19, 2017 , ... Yesterday, the President of the ... there are two sides. There are not two sides to hatred, bigotry, discrimination, and ... and prejudice, and the NPEIV stands against all forms of such hatred and discrimination ...
(Date:8/18/2017)... , ... August 18, 2017 , ... More than 20,000 ... Republic of Congo (DRC) thanks to an ambitious venture that conjoined the passions of ... the generous support of the Liberty community. These shoes will save lives from the ...
(Date:8/18/2017)... ... 18, 2017 , ... Mediaplanet today announces the launch of ... and highlighting the importance of proactive eye and ear health. The campaign focuses ... innovations in hearing aid technology. , In this issue, the American Speech-Language-Hearing ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... services to communities in east Texas, is launching a regional charity effort to ... Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 ...
Breaking Medicine News(10 mins):
(Date:8/17/2017)... , Aug. 17, 2017 Bio-Ess Laboratories, LLC Chief Science ... antibody titer and present new data on Cell-Ess® Universal Titer ... Boston, MA August 21-25.  The Bioprocessing Summit convenes ... bioprocess challenges. ... Optimizer ...
(Date:8/15/2017)... OCEANSIDE, Calif. , Aug. 15, 2017  AOTI Inc. announced ... Advanced Oxygen Therapy Inc., has recently opened a New York City ... the ever-increasing usage of its unique Topical Wound Oxygen (TWO 2 ... approved by the Accreditation Commission for Health Care (ACHC) under the ... ...
(Date:8/8/2017)... 2017   Second-quarter ... (GAAP) loss per share from continuing operations ... increased 16 percent to $110 million ... percent to $161 million ... continuing operations increased 8 percent to $0.93 ...
Breaking Medicine Technology: